TELIX PHARMACEUTICALS US

Lobbying client · Indiana · filed 2025 to 2026

Diagnostic radiopharmaceutical providing precision medicine to patients in the U.S.

$142,000 Reported spend

5 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page is grouped by the client's LDA id (69087), not by name.

Firms hired 1

LIBERTY PARTNERS GROUP, LLC $142,000 5 filings

Reported by year 2 years

2026 $90,000 2 filings
2025 $52,000 3 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

Centers For Medicare and Medicaid Services (CMS) 4
Food & Drug Administration (FDA) 4
Health & Human Services, Dept of (HHS) 4
HOUSE OF REPRESENTATIVES 4
SENATE 4

Recent filings 5 total

Q2

LIBERTY PARTNERS GROUP, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $40,000 income · posted Jul 20, 2026

View → Q1

LIBERTY PARTNERS GROUP, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $50,000 income · posted Apr 17, 2026

View → Q4

LIBERTY PARTNERS GROUP, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $52,000 income · posted Jan 20, 2026

View → Q3

LIBERTY PARTNERS GROUP, LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · posted Oct 20, 2025

View → RR

LIBERTY PARTNERS GROUP, LLC

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 8, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.